Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, BXP, Inc. insiders sold a net $2.2M of stock across 33 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Nov 7, 2025.
The trade is 130.3% of the 13,872 shares held after it.
2 other insiders sold within 30 days.
298 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP and CFO LABELLE MICHAEL E sold about $1.2M of BXP on Jun 9, 2026; 2 other insiders sold within 30 days and 298 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Nov 7, 2025.
The trade is 137.6% of the 5,839 shares held after it.
2 other insiders sold within 30 days.
298 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP and CFO LABELLE MICHAEL E sold about $538.4K of BXP on Jun 9, 2026; 2 other insiders sold within 30 days and 298 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 21, 2026.
The trade is 643.1% of the 311 shares held after it.
2 other insiders sold within 30 days.
298 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, CLO and Secretary Kevorkian Eric G sold about $119.7K of BXP on May 22, 2026; 2 other insiders sold within 30 days and 298 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 11, 2023.
The trade is 8.7% of the 2,311 shares held after it.
2 other insiders sold within 30 days.
298 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, CLO and Secretary Kevorkian Eric G sold about $12.0K of BXP on May 21, 2026; 2 other insiders sold within 30 days and 298 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 25, 2025.
2 other insiders sold within 30 days.
298 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President Otteni Peter V sold about $287.2K of BXP on May 20, 2026; 2 other insiders sold within 30 days and 298 funds added in the latest 13F quarter.
33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BXP planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
BXP mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Davis Real Estate Fund
$5.9M position · as of 2026-06-30
4.6%
Baron Real Estate Income Fund
$13.6M position · as of 2026-06-30
4.6%
Invesco S&P 500 Equal Weight Real Estate ETF
$3.5M position · as of 2026-07-31
3.5%
Dunham Real Estate Stock Fund
$2.4M position · as of 2026-07-31
3.1%
MFS Global Real Estate Portfolio
$4.5M position · as of 2026-06-30
2.9%
MFS Global Real Estate Fund
$56.2M position · as of 2026-05-31
2.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Owen D. Thomas.
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$23.0M
$24.5M
$9.1M
-8%
-19%
2024
$12.8M
$11.6M
$5.0M
-4%
-6%
2023
$13.0M
$10.0M
$5.9M
-14%
-22%
2022
$13.1M
$2.6M
$5.8M
-22%
-24%
2021
$12.9M
$19.7M
$6.0M
+26%
+22%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $2.2M sold by insiders over 180 days, 298 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.5B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BXP
FY Dec 2025
$3.5B
FY Dec 2024
$3.4B
FY Dec 2023
$3.3B
FY Dec 2022
$3.1B
FY Dec 2021
$2.9B
Jun 2026
$895.7M
Mar 2026
$872.1M
Dec 2025
$877.1M
Sep 2025
$871.5M
Jun 2025
$868.5M
Mar 2025
$865.2M
Dec 2024
$858.6M
Sep 2024
$859.2M
At each fiscal year end
Single quarter
Net margin, TTM
+8.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM BXP
FY Dec 2025
+7.9%
FY Dec 2024
+0.4%
FY Dec 2023
+5.8%
FY Dec 2022
+27.3%
FY Dec 2021
+17.2%
Jun 2026
+7.7%
Mar 2026
+11.6%
Dec 2025
+28.3%
Sep 2025
-14.0%
Jun 2025
+10.2%
Mar 2025
+7.1%
Dec 2024
-26.7%
Sep 2024
+9.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.1B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BXP
FY Dec 2025
$1.0B
FY Dec 2024
$1.0B
FY Dec 2023
$1.1B
FY Dec 2022
$1.1B
FY Dec 2021
$982.2M
Jun 2026
$421.0M
Mar 2026
$125.7M
Dec 2025
$362.7M
Sep 2025
$231.6M
Jun 2025
$281.5M
Mar 2025
$152.6M
Dec 2024
$312.5M
Sep 2024
$234.5M
At each fiscal year end
Single quarter
Debt to equity
0.64x
long-term debt only, 2021-12-31 (54 months older than the period end); equity 2026-06-30
Debt to equity BXP
FY Dec 2025
0.64x
FY Dec 2024
0.61x
FY Dec 2023
0.56x
FY Dec 2022
0.54x
FY Dec 2021
0.57x
Jun 2026
0.64x
Mar 2026
0.64x
Dec 2025
0.64x
Sep 2025
0.66x
Jun 2025
0.63x
Mar 2025
0.62x
Dec 2024
0.61x
Sep 2024
0.57x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.39x
TTM operating cash flow over long-term debt only, 2021-12-31 (54 months older than the period end)
Cash flow to debt BXP
FY Dec 2025
0.38x
FY Dec 2024
0.37x
FY Dec 2023
0.39x
FY Dec 2022
0.39x
FY Dec 2021
0.34x
Jun 2026
0.39x
Mar 2026
0.36x
Dec 2025
0.38x
Sep 2025
0.37x
Jun 2025
0.37x
Mar 2025
0.38x
Dec 2024
0.37x
Sep 2024
0.38x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+5.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity BXP
FY Dec 2025
+5.2%
FY Dec 2024
+0.3%
FY Dec 2023
+3.2%
FY Dec 2022
+14.2%
FY Dec 2021
+8.4%
Jun 2026
+5.7%
Mar 2026
+6.1%
Dec 2025
+5.2%
Sep 2025
-3.7%
Jun 2025
+0.1%
Mar 2025
-0.1%
Dec 2024
+0.3%
Sep 2024
+6.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets BXP
FY Dec 2025
+1.1%
FY Dec 2024
+0.1%
FY Dec 2023
+0.8%
FY Dec 2022
+3.6%
FY Dec 2021
+2.2%
Jun 2026
+1.2%
Mar 2026
+1.3%
Dec 2025
+1.1%
Sep 2025
-0.8%
Jun 2025
+0.0%
Mar 2025
-0.0%
Dec 2024
+0.1%
Sep 2024
+1.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital BXP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed BXP
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
32.74x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BXP
FY Dec 2025
38.78x
FY Dec 2024
743.60x
FY Dec 2023
57.99x
FY Dec 2022
12.51x
FY Dec 2021
36.33x
Jun 2026
35.65x
Mar 2026
26.08x
Dec 2025
38.78x
Sep 2025
n/a
Jun 2025
2,249.00x
Mar 2025
n/a
Dec 2024
743.60x
Sep 2024
34.83x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$12.5B
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term debt only, 2021-12-31 (54 months older than the period end), minus cash 2026-06-30
Enterprise value BXP
FY Dec 2025
$12.5B
FY Dec 2024
$13.8B
FY Dec 2023
$12.8B
FY Dec 2022
$13.2B
FY Dec 2021
$20.8B
Jun 2026
$13.4B
Mar 2026
$11.0B
Dec 2025
$12.5B
Sep 2025
$14.2B
Jun 2025
$13.5B
Mar 2025
$13.5B
Dec 2024
$13.8B
Sep 2024
$14.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.7%
TTM free cash flow over market value at close 2026-10-27
FCF yield BXP
FY Dec 2025
+9.6%
FY Dec 2024
+8.9%
FY Dec 2023
+10.3%
FY Dec 2022
+10.4%
FY Dec 2021
+5.5%
Jun 2026
+10.8%
Mar 2026
+12.2%
Dec 2025
+9.6%
Sep 2025
+8.3%
Jun 2025
+9.2%
Mar 2025
+9.7%
Dec 2024
+8.9%
Sep 2024
+8.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.01x
P/E over trailing EPS growth of 6100%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing BXP
FY Dec 2025
0.02x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.18x
FY Dec 2021
n/a
Jun 2026
0.01x
Mar 2026
n/a
Dec 2025
0.02x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.40x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BXP ranks highest on financial health (79th percentile) and profitability (57th), and lowest on insider conviction (9th), among Real Estate peers.
Profitability
57
Inputs
Return on equity+5.7% · 61 pct, sector of 230
Return on assets+1.2% · 52 pct, sector of 255
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employedassets or current liabilities not filed
Financial health
79
Inputs
Debt to equity0.64x · 69 pct, sector of 210
Cash flow to debt0.39x · 88 pct, sector of 215
Growth
41
Inputs
Revenue growth, YoY+2.2% · 41 pct, sector of 244
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
9
Inputs
Net Form 4 buying (codes P and S), 180d-$2.2M · 19 pct, sector of 156
Insider buyers, 180d0 · 0 pct, sector of 158
Institutional and government
48
Inputs
Funds adding, latest quarter298 · 85 pct, sector of 171
Congress net buyers, 365d-1 · 11 pct, sector of 36
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
45
Inputs
Short interest, % of float+7.9% · 25 pct, sector of 256
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.5% · 64 pct, sector of 212
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BXP filings, in plain words
Are BXP insiders buying or selling BXP?
In the 180 days to 2026-10-28, BXP insiders were net sellers, a net $2.2M across purchases and sales reported on Form 4, by 3 sellers.
Have members of Congress traded BXP?
Yes. In the year to 2026-10-28, 1 House member disclosed buying BXP and 2 House members disclosed selling it; the latest on record is a sale by Julia Letlow dated 2026-02-20.
Read the full summary
In the 180 days to 2026-10-28, BXP insiders were net sellers of BXP, a net $2.2M across purchases and sales reported on Form 4 by 3 sellers. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying BXP and 2 members disclosed selling it; the latest on record is a sale by Julia Letlow dated 2026-02-20. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.